BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

FemHealth Focus

FDA Approves Phase I/II Trial for Leads Biolabs' Anti-MUC16/CD3 Bispecific Antibody in Advanced Solid Tumors.

The study is a multicenter, open-label, dose-escalation and expansion phase Ⅰ/Ⅱ clinical study. The phase Ⅰ part aims to evaluate the safety, to...

June 19, 2023 | News

Fertilix Successfully Blocks Low-Dose Chemical Damage in Plastic Consumer Products

The study, led by Professor Joel Drevet, examined two common chemicals widely used in the plastic industry: dibutyl phthalate and bisphenol AF. These chemi...

May 19, 2023 | News

Fujitsu partners with Takeda and National Cancer Center Japan to analyze and visualize ovarian cancer patient journey

Fujitsu today announced that it has conducted a joint research project with Takeda Pharmaceutical Company Limited and the National Cancer Center Japan to a...

May 12, 2023 | News

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

CTH-004 has shown promising results in animal models of ovarian cancer and will be evaluated in a clinical trial under a research and development...

April 28, 2023 | News

500 women join Australia's landmark maternity medical device study

The study was led by Principal Investigators Professor Michael Nicholls, Professor Andrew Bisits and Michelle de Vroom at two Aust...

April 20, 2023 | News

Roche Diagnostics India Unveils #BeYourOwnShero Campaign to Educate Women About Cervical Cancer Prevention

Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. D...

April 05, 2023 | News

Genes that Form Specific Bones In the Womb Heal them Later in Life

Genes long known to control the formation of bones before birth also control bone healing later in life, a new study found. Led by researcher...

March 21, 2023 | News

Maternity and Baby Brand Momcozy Launches 'Parachute Care Program' to Support Breastfeeding Journeys

The Parachute Care Program aims to be a companion for moms from pregnancy through the early stages of motherhood. "We all appreciate how difficul...

March 02, 2023 | News

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test. Highlights: New test integ...

February 03, 2023 | News

AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China

AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in neurological, psyc...

January 17, 2023 | News

In Vitro Fertilization Services Industry to be Boosted by Innovative Technologies

In vitro fertilization (IVF), one type of assisted reproductive technology (ART), is becoming more popular due to an increase in infertility rates worldwid...

December 26, 2022 | News

1 in 3 women suffer from Iron Deficiency symptoms including tiredness and dizziness

Launches 'Sangobion Anaemia meter', a convenient online tool that empowers consumers to screen themselves for the risks of iron deficiency, the most c...

November 28, 2022 | News

Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal contraceptive medicines

Cyclica Inc., a neo-biotech that is unlocking the protein universe to discover the medicines of tomorrow, is developing new, non-hormonal contraceptives fo...

November 15, 2022 | News

Pxierra to launch world's first non-contact heart rate & breathe rate measurement AI baby monitor

Pxierra is committed to providing parents with the latest technology to help them care for their newborns. For more information about Pxierra and its new A...

September 02, 2022 | News

Stay Connected